HRTG(HRTG)
HRTG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $861M | $899M |
| Low | $858M | $896M |
| High | $865M | $903M |
| EBITDA Avg | $563M | $588M |
| Low | $561M | $586M |
| High | $565M | $590M |
| EBIT Avg | $553M | $577M |
| Low | $551M | $575M |
| High | $555M | $580M |
| Net Income Avg | $131M | $139M |
| Low | $128M | $129M |
| High | $139M | $164M |
| EPS Avg | $4.32 | $4.73 |
| Low | $4.14 | $4.17 |
| High | $4.49 | $5.29 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $213M | $217M | $219M | $220M | $222M | $227M | $230M |
| Low | $212M | $216M | $218M | $219M | $221M | $225M | $229M |
| High | $214M | $218M | $220M | $221M | $224M | $228M | $231M |
| EBITDA Avg | $139M | $142M | $143M | $144M | $145M | $148M | $151M |
| Low | $138M | $141M | $142M | $143M | $145M | $147M | $150M |
| High | $140M | $143M | $144M | $145M | $146M | $149M | $151M |
| EBIT Avg | $137M | $139M | $141M | $141M | $143M | $145M | $148M |
| Low | $136M | $138M | $140M | $141M | $142M | $145M | $147M |
| High | $137M | $140M | $141M | $142M | $144M | $146M | $149M |
| Net Income Avg | $37M | $19M | $41M | $39M | $40M | $19M | $47M |
| Low | $37M | $19M | $40M | $39M | $39M | $19M | $47M |
| High | $37M | $19M | $41M | $39M | $40M | $19M | $48M |
| EPS Avg | $1.20 | $0.61 | $1.32 | $1.27 | $1.29 | $0.63 | $1.53 |
| Low | $1.19 | $0.60 | $1.31 | $1.26 | $1.28 | $0.63 | $1.52 |
| High | $1.20 | $0.61 | $1.33 | $1.28 | $1.30 | $0.63 | $1.55 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |